← All stocks

COMPUGEN LTD

CGEN Scheduled selling only

CIK 0001119774 #3768 in the set updated 20 Sep 2026

Bought (120 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$118.28K

$0.00 on a plan · $118.28K straight out of an exercise

Sold at will

$0.00

0 of 11 sales

Net

−$118.28K

$0.00 against sales at will

By person

10 insiders · 11 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Levine Zurit

SVP, Business Development

—

$75.34K (8) scheduled

−$75.34K

47,375

0.0501%

$118.44K

+61.3%

Ophir Eran

President and CEO

—

$42.93K (3) scheduled

−$42.93K

11,375

0.0120%

$28.44K

0.0%

Silberman David

Chief Financial Officer

—

55,000

0.0582%

$137.50K

+54.9%

Kredo Russo Sharon

SVP, Research & Discovery

—

37,500

0.0397%

$93.75K

+92.3%

Mahler Michelle

Chief Medical Officer

—

36,625

0.0387%

$91.56K

+58.4%

Livnat Savitzky Kinneret

Director

—

20,850

0.0221%

$52.13K

+56.2%

ZWEIFACH SANFORD S

Director

—

20,180

0.0213%

$50.45K

+59.1%

Halevy Gilead

Director

—

18,907

0.0200%

$47.27K

+65.7%

Perry Eran

Director

—

17,500

0.0185%

$43.75K

+75.0%

Hukkelhoven Mathias

Director

—

17,500

0.0185%

$43.75K

+75.0%

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 22

Amendments (4/A) skipped 1

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 11

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 154,375

History held since 30 Mar 2026